Home › Funds › Kera Capital Partners, Inc. › JNJ

Kera Capital Partners, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Kera Capital Partners, Inc. reported holding 47,149 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 1.01% of its reported portfolio and ranking #20 among its reported holdings. Kera Capital Partners, Inc. has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)47.15K sh
Reported value held$12.23M
Portfolio Weight1.01%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kera Capital Partners, Inc.'s JNJ position evolved

Kera Capital Partners, Inc. first disclosed a stake in JNJ in Q4 2024 at 2,430 shares (US$351K). The position peaked in Q3 2026 at 47,149 shares, worth US$12.2M. Across 8 filings, Kera Capital Partners, Inc. increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 47,149 shares valued at US$12.2M — an increase of 3,273 shares quarter over quarter.. Notable position changes include a 152% increase in Q3 2025 (shares rose 11% over the following quarter), a 152% increase in Q4 2025 (shares rose 18% over the following quarter), a 53% increase in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.43K $351.43K New
Q1 2025 3.08K $510.29K Add
Q2 2025 4.12K $628.73K Add
Q3 2025 10.38K $1.93M Add
Q4 2025 26.22K $5.96M Add
Q1 2026 40.09K $9.80M Add
Q2 2026 43.88K $11.14M Add
Q3 2026 47.15K $12.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Kera Capital Partners, Inc. held JNJ?

Kera Capital Partners, Inc. has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Kera Capital Partners, Inc.'s current position in JNJ?

As of Q3 2026, Kera Capital Partners, Inc. holds 47.15K shares of JNJ (JOHNSON & JOHNSON), valued at $12.23M, representing 1.01% of its reported portfolio and ranking #20.

Has Kera Capital Partners, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Kera Capital Partners, Inc. increased its position in JNJ. The position peaked in Q3 2026 at 47.15K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.